{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":null,"indication":null,"name":"SHORTER","nct_id":"NCT04422132","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=shorter-nct04422132. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Patients will receive treatment to the prostate fossa +/- nodes in 32.5 Gy in 5 fractions. Patients receiving 32.5 Gy in 5 fractions cannot be treated on consecutive days.","label":"ARM 1 - 2 weeks","type":"ACTIVE_COMPARATOR"},{"description":"Patients will receive treatment to the prostate fossa +/- nodes in 55 Gy in 20 fractions.","label":"ARM 2 - 4 weeks","type":"ACTIVE_COMPARATOR"}],"collaborators":["Viewray Inc."],"completion_date":{"date":"2033-12-31","type":"ESTIMATED"},"conditions":["Prostate Cancer"],"enrollment":{"count":137,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"5 days Radiation Therapy (32.5 Gy in 5 fractions)","otherNames":[],"type":"RADIATION"},{"name":"20 days Radiation therapy (55 Gy in 20 fractions)","otherNames":[],"type":"RADIATION"}],"last_update":"2026-10-14","lead_sponsor":"Weill Medical College of Cornell University","official_title":"Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2025-12-31","type":"ACTUAL"},"primary_outcomes":[{"measure":"Change in the Number of Patient-reported GI Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)","timeFrame":"Baseline"},{"measure":"Change in the Number of Patient-reported GI Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)","timeFrame":"24 months"},{"measure":"Change in the Number of Patient-reported GU Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)","timeFrame":"Baseline"},{"measure":"Change in the Number of Patient-reported GU Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)","timeFrame":"24 months"}],"references":[{"citation":"Marciscano AE, Wolfe S, Zhou XK, Barbieri CE, Formenti SC, Hu JC, Molina AM, Nanus DM, Nauseef JT, Scherr DS, Sternberg CN, Tagawa ST, Nagar H. Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER). BMC Cancer. 2023 Aug 22;23(1):781. doi: 10.1186/s12885-023-11278-3.","pmid":"37608258","type":"DERIVED"}],"start_date":{"date":"2020-09-24","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks","url":"https://clinicaltrials.gov/study/NCT04422132"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/shorter-nct04422132"}